All Regulation articles – Page 29
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
Business
Mango and Zara sign up to 'detox' plan
Greenpeace campaign to remove hazardous chemicals from the clothing industry is garnering big name support
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe
-
Business
Bomb chemicals face EU regulation
Retailers say chemical producers and distributors must share regulatory burden
-
Business
Regorafenib approved in US
Stivarga tablets approved for treatment of advanced colorectal cancer
-
Business
Measuring nano the European way
Report concludes that companies will need lots of methods to define nanomaterials
-
Business
Pineapple gel approved for burns
EU regulators approve NexoBrid gel from MediWound for removal of scab tissue
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests
-
Business
New cystic fibrosis drug in EU
Ivacaftor works by helping defective proteins function more normally
-
Business
New US chemical rules edge nearer
Chemical manufacturers would have to produce safety data for their products
-
Business
Drugs top EU counterfeit imports
In 2011, medicines topped the list of fake products entering the EU
-
Business
UK urged to clean up London air
Think tank says ‘invisible’ pollution is public health problem comparable to obesity and alcohol
-
Business
First HIV drug approved as prevention
Truvada tablets can reduce the risk of infection for an HIV-negative person
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
-
Business
Brazil hits BASF with worker payout
BASF and Shell have been ordered to pay BRL1 billion (£300 million) to compensate employees for damage to their health